• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Evofem Biosciences, Inc. - Common Stock (NQ: EVFM )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 0.4405 (85)
    Ask (Size) 0.4450 (126)
    Prev. Close 0.4782
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 100,328,686
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    EVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024
    Evofem Biosciences just reported results for the first quarter of 2024. 
    Via InvestorPlace
    InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Merger Target Expects ‘Fourth Consecutive Year of Net Sales Growth’
    Via Investor Brand Network

    Performance

    More News

    Read More
    EVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023
    Via InvestorPlace
    InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Acquisition Target Reports Increased Product Sales, Ongoing Revenue Growth
    Via Investor Brand Network
    Why Is Evofem (EVFM) Stock Up 85% Today?
    Via InvestorPlace
    Evofem Biosciences's Return On Capital Employed Insights
    Via Benzinga
    Evofem Biosciences Return On Capital Employed Overview
    Via Benzinga
    InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Potential Acquisition Releases FY 2023 Preliminary Financial Report
    Via Investor Brand Network
    EVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFM
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Definitive Agreement to Acquire Evofem Biosciences Inc.
    Via Investor Brand Network
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Why Is Life Sciences-Focused Aditxt Stock Trading Higher Today?
    Via Benzinga
    EVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
    From Aditxt, Inc.
    Via Business Wire
    CapitalGainsReport: Thursday’s OTC Watchlist (EVFM, EPAZ, NWBO, VDRM)
    Via News Direct
    Evofem Biosciences Inc. (OTC:EVFM): Here Are Latest News & Updates
    Via News Direct
    OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
    Via Benzinga
    Why Evofem Biosciences Shares Are Plunging Today?
    Via Benzinga
    4 Analysts Have This to Say About Evofem Biosciences
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
    Via Benzinga
    Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
    Via Benzinga
    Evofem Biosciences Phase 3 EVOGUARD Trial Puts October Catalyst In Play, Here’s Why Investors Are Paying Attention ($EVFM)
    Via AB Newswire
    Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.